Ganciclovir/immunoglobulin combination therapy for the treatment of human cytomegalovirus-associated interstitial pneumonia in bone marrow allograft recipients

Transplantation. 1988 Dec;46(6):905-7.

Authors

G M Schmidt¹, A Kovacs, J A Zaia, D A Horak, K G Blume, A P Nademanee, M R O'Donnell, D S Snyder, S J Forman

Affiliation

¹ Department of Hematology, City of Hope National Medical Center, Duarte, California 91010.

PMID: 2849818

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Acyclovir / analogs & derivatives*
Acyclovir / therapeutic use
Adolescent
Adult
Antibodies, Viral / analysis
Bone Marrow Transplantation*
Combined Modality Therapy
Cytomegalovirus / immunology
Cytomegalovirus Infections / drug therapy
Cytomegalovirus Infections / etiology
Cytomegalovirus Infections / therapy*
Female
Ganciclovir
Humans
Immunization, Passive*
Male
Middle Aged
Postoperative Complications / drug therapy
Postoperative Complications / therapy*
Pulmonary Fibrosis / drug therapy
Pulmonary Fibrosis / etiology
Pulmonary Fibrosis / therapy*

Substances

Antibodies, Viral
Ganciclovir
Acyclovir

Grants and funding